Abstract
Background: Lung cancer is a leading cause of cancer mortality. It is one of the most abundant cancer types clinically, with 2 million new cases diagnosed yearly.
Aims: Using clinically collected non-small cell lung cancer (NSCLC) samples, we sought to hypothesize an innovative intact signaling cascade for the disorder.
Methods: We dissected snap-frozen NSCLC tissues along with sibling-paired nearby non-tumorous tissues from 108 NSCLC patients. We measured the expression levels of miR-451/ETV4/MMP13 using qRT-PCR and did a thorough investigation of the molecular mechanism for the signaling axis in NSCLC cell line A549. We also studied the epithelial-mesenchymal transition (EMT) process.
Results: The activity of miR-451 was significantly decreased in NSCLC tissues, while the expression levels of ETV4 and MMP13 were remarkably increased. At the same time, miR-451 levels maintained a declining trend across TNM stage I–III. Inversely, ETV4 and MMP13 increased as the TNM stage increased. The miR-451/ETV4/MMP13 signaling axis was closely associated with prognosis in NSCLC patients. Based on in vitro experiments, ETV4 was a direct targeting factor for miRNA-451. Meanwhile, ETV4 promoted the tumor properties of NSCLC cells by directly activating MMP13. Silencing MMP13 blocked the EMT progress of NSCLC cells.
Conclusion: Overall, we hypothesized an impeccable signaling pathway for NSCLC from a new aspect, and this can offer alternative insights for a better understanding of the disorder.
Keywords: ETV4, Lung cancer, miR-451, MMP13, Non-small cell lung cancer, TNM stage I–III.
[http://dx.doi.org/10.1016/S0140-6736(21)00312-3] [PMID: 34273294]
[http://dx.doi.org/10.1158/1055-9965.EPI-19-0221] [PMID: 31575553]
[http://dx.doi.org/10.1016/j.path.2019.11.002] [PMID: 32005431]
[http://dx.doi.org/10.1016/j.soc.2016.02.001] [PMID: 27261907]
[http://dx.doi.org/10.1007/s00408-020-00407-5] [PMID: 33175991]
[http://dx.doi.org/10.3322/caac.21332] [PMID: 26742998]
[http://dx.doi.org/10.1016/j.mcna.2018.12.006] [PMID: 30955514]
[http://dx.doi.org/10.3390/ijms21134569] [PMID: 32604993]
[http://dx.doi.org/10.3390/ijms20246249] [PMID: 31835747]
[http://dx.doi.org/10.1038/s41598-020-65920-2] [PMID: 32494004]
[http://dx.doi.org/10.1371/journal.pone.0171751] [PMID: 28199399]
[http://dx.doi.org/10.1101/gad.6.3.481] [PMID: 1547944]
[PMID: 22425584]
[http://dx.doi.org/10.1093/cercor/bhw372] [PMID: 27909004]
[http://dx.doi.org/10.1038/ng.476] [PMID: 19898483]
[http://dx.doi.org/10.1038/nature10730] [PMID: 22217937]
[http://dx.doi.org/10.1002/path.2859] [PMID: 21404275]
[http://dx.doi.org/10.1016/S0021-9258(19)89457-7] [PMID: 8207000]
[http://dx.doi.org/10.1242/jcs.027201] [PMID: 18827017]
[http://dx.doi.org/10.1016/j.trecan.2015.07.009] [PMID: 28741564]
[http://dx.doi.org/10.1186/s13058-018-0992-0] [PMID: 29996935]
[http://dx.doi.org/10.1016/j.mayocp.2019.01.013] [PMID: 31378236]
[http://dx.doi.org/10.1158/1541-7786.MCR-13-0229] [PMID: 23989931]
[http://dx.doi.org/10.1074/jbc.M408017200] [PMID: 15466854]
[http://dx.doi.org/10.3390/diagnostics10080547] [PMID: 32751899]
[http://dx.doi.org/10.1074/jbc.271.3.1544] [PMID: 8576151]
[http://dx.doi.org/10.3390/biom9030107] [PMID: 30889876]
[http://dx.doi.org/10.1016/j.biopha.2020.110909] [PMID: 33227701]
[PMID: 29637008]
[http://dx.doi.org/10.2147/OTT.S230963] [PMID: 31908476]
[PMID: 31389598]
[PMID: 30229828]